Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma

Nevoid melanoma is a subtype of melanoma that histologically resembles a melanocytic nevus. Two subtypes have been proposed for nevoid melanoma, namely papillomatous and maturing. Here, we report the case of a 67‐year‐old woman who developed two nevoid melanomas on her scalp with composite histological features of papillomatous and maturing subtypes after electrocautery of a nearby solitary scalp papule. The histology of both lesions was very similar, papillary in shape, and both comprised two melanocyte populations, including large atypical melanocytes and small non‐atypical melanocytes. Whole‐exome sequencing was performed in one of the two lesions, which revealed a high mutation burden (17 mutations/megabase) with co‐deletion of CDKN2A. Additional immunohistochemistry revealed that the large and small melanocytes in both lesions were completely negative for p16 and MTAP. A final diagnosis of nevoid melanoma was made. To our knowledge, this is the first report of a nevoid melanoma with both features of papillomatous and maturing subtypes. Pathologists should be aware of this subtype of melanoma to avoid misdiagnosis as a mitotically active melanocytic nevus. In this case, immunohistochemistry for p16 and MTAP, in addition to molecular analysis, helped in the final diagnosis.

[1]  P. Googe,et al.  Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms , 2021, The American Journal of dermatopathology.

[2]  K. Ichimura,et al.  Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma , 2020, Modern Pathology.

[3]  B. Wood,et al.  Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study. , 2020, The American Journal of dermatopathology.

[4]  J. Wilmott,et al.  Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy , 2019, The American journal of surgical pathology.

[5]  A. Halpern,et al.  Massively parallel sequencing analysis of benign melanocytic naevi , 2019, Histopathology.

[6]  N. Le Stang,et al.  MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma , 2019, Modern Pathology.

[7]  D. Elder,et al.  WHO classification of skin tumours , 2018 .

[8]  S. Miyano,et al.  Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. , 2017, Blood.

[9]  R. Dummer,et al.  The Genetic Evolution of Melanoma from Precursor Lesions. , 2015, The New England journal of medicine.

[10]  K. Busam,et al.  Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma , 2015, Journal of cutaneous pathology.

[11]  Z. Szallasi,et al.  Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Yu Fang,et al.  Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi , 2009, The American journal of surgical pathology.

[13]  A. Bosserhoff,et al.  Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. , 2003, The American journal of pathology.

[14]  J. Grichnik,et al.  Malignant Melanoma With Paradoxical Maturation , 2000, The American journal of surgical pathology.

[15]  M. Bulyk,et al.  Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. , 1996, Cancer research.

[16]  E. Hovig,et al.  Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. , 1996, British Journal of Cancer.